At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens
Venetoclax combined with azacitidine (VenAza) in patients with acute myeloid leukemia (AML) presents a high incidence of cytopenias and infections during initial treatment cycles, making early management challenging. To address this, our center implemented an At-Home (AH) program during the VenAza i...
Gespeichert in:
Veröffentlicht in: | Cancers 2024-12, Vol.16 (24), p.4274 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!